Kreos Capital — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Poxelpoxel.comSep 2014

Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders.

BiotechHealthtechMedical DevicesLyon, FR

Co-investorsAndera Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.